Ophthalmology Times Staff Reports


UCSF debuts new home for ophthalmology programs

The University of California San Francisco this week debuted the UCSF Wayne and Gladys Valley Center for Vision, bringing its vision care and research facilities under one roof.

AMA supports House plan to ease Medicare loan repayment terms

The American Medical Association is expressing its support for provisions in proposed Continuing Resolution legislation in Congress that could offer relief to financially strapped physician practices.

First treatment for neuromyelitis optica spectrum disorder receives FDA approval

Intravitreal injection treats rare autoimmune disease of the central nervous system

Aflibercept gains new approval, recommendation

October 03, 2012

Aflibercept (Eylea, Regeneron) has gained FDA approval for treatment of macular edema following CRVO and recommendation for approval by the CHMP for treatment of neovascular AMD.

Rho-kinase inhibitor in phase IIa study

October 03, 2012

A phase IIa proof of concept study of a novel rho-kinase (ROCK) inhibitor (AMA0076, Amakem NV) is now underway in patients with glaucoma and ocular hypertension.

Valeant acquires AMD treatment

October 03, 2012

QLT Inc. announces that it has completed sale of verteporfin for injection (Visudyne) to Valeant Pharmaceuticals International Inc.